An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma

Author： Michon J.M.   Hartmann O.   Bouffet E.   Meresse V.   Coze C.   Rubie H.   Bordigoni P.   Cattiaux E.   Ward N.   Bernard J.-L.   Lemerle J.   Zucker J.-M.   Philip T.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.34, Iss.7, 1998-06, pp. : 1063-1069

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant Human Granulocyte-Macrophage Colony-stimulating Factor After Combined Chemotherapy in High-grade Non-Hodgkin's Lymphoma--a Randomised Pilot Study

By Bergmann L.   Karakas T.   Knuth A.   Lautenschlager G.   Mitrou P.S.   Hoelzer D.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2164-2168

Elsevier

Access to resources Recommend Favorite

A Single-blind, Randomised, Vehicle-controlled Dose-finding Study of Recombinant Human Granulocyte Colony-stimulating Factor (Lenograstim) in Patients Undergoing Chemotherapy for Solid Cancers and Lymphoma

By Seymour A.-M.   de Campos E.   Thatcher N.   De Greve J.   Cunningham D.   Howell A.   Tueni E.   Bron D.G.   Steward W.P.   Berdel W.E.   Knuth A.   Lorenz J.   Timothy A.R.   Yver A.   Richards M.A.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2157-2163

Elsevier

Access to resources Recommend Favorite

A Phase II Double-Blind Randomized Study of the Simultaneous Administration of Recombinant Human Interleukin-6 and Recombinant Human Granulocyte Colony-Stimulating Factor Following Paclitaxel and Carboplatin Chemotherapy in Patients with Advanced Epithelial Ovarian Cancer

By Hochster H.   Speyer J.L.   Mandeli J.P.   Runowicz C.   Wadler S.   Berk G.   Wallach R.   Holland J.F.   for the New York Gynecologic Oncology Group  

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 292-297

Elsevier

Access to resources Recommend Favorite

Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy: A multicenter open randomized phase III study

By Masucci Giuseppe   Broman Peter   Kelly Charles   Lindahl Sten   Malmberg Lena   Reizenstein Johan   Ålenius Martin   Lewensohn Rolf  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 247-256

Humana Press, Inc

Access to resources Recommend Favorite

A phase I study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support in the treatment of advanced non-small cell lung cancer

By Mori K.   Hirose T.   Machida S.   Yokoyama K.   Tominaga K.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 503-505

Elsevier

Access to resources Recommend Favorite